Exposure, Environmental, Genetic Predisposition
Conditions
Brief summary
The purpose of this study is to use multi-omics testing on samples collected from Mayo Clinic patients to build and expand on what has been learned about genomic data.
Interventions
None listed
Sponsors
Mayo Clinic
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Age ≥ 18 years * Registered Mayo Clinic patient * Able to provide informed written consent * Able to receive mail and packages within a United States (US) state * Able to collect and ship samples within a US state
Exclusion criteria
* Active hematological cancer or history of a hematological cancer * Allogeneic Bone Marrow Transplant (e.g., samples from autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant) * Other co-morbidity that, in physician's opinion, would interfere with patient's ability to participate in the study (e.g., reduced ability to comprehend, i.e., dementia, intellectual disability, etc.)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Creation of a unique integrated asset of multi-omics data | Up to 5 years | A variety of patient cohorts will be ascertained throughout this study. Data will be made available to researchers to query correlations of disease states and clinical outcomes to multi-omics findings. These insights will be invaluable to creating omics-informed care plans in the future. Standard descriptive statistics approaches will be used for analysis. |
Countries
United States
Outcome results
None listed